2024
Parent Perspectives on Nirsevimab for Their Newborn.
Hinderstein S, Aragona E, Loyal J. Parent Perspectives on Nirsevimab for Their Newborn. 2024, 154 PMID: 39587878, DOI: 10.1542/peds.2024-067532.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus prophylaxisRSV disease severityMaternal RSV vaccineHealth Belief ModelHealthy newbornsRSV vaccineRSV infectionParents of newbornsNewborn unitSyncytial virusNirsevimabSide effectsNewbornsBelief ModelPediatric hospitalMonoclonal antibodiesDisease severityCOVID-19 vaccineProphylaxisVaccineIncreasing overall awarenessInfantsPediatrician's recommendationPositively influence decision
2017
Development of quality metrics for ambulatory pediatric cardiology: Infection prevention
Johnson JN, Barrett CS, Franklin WH, Graham EM, Halnon NJ, Hattendorf BA, Krawczeski CD, McGovern JJ, O'Connor MJ, Schultz AH, Vinocur JM, Chowdhury D, Anderson JB. Development of quality metrics for ambulatory pediatric cardiology: Infection prevention. Congenital Heart Disease 2017, 12: 756-761. PMID: 28741863, DOI: 10.1111/chd.12519.Peer-Reviewed Original ResearchConceptsInfection preventionPediatric cardiologyAntibiotic prophylaxisRheumatic feverHand hygieneAdult CongenitalAmbulatory practiceRespiratory syncytial virus prophylaxisAsplenia/hyposplenismInfluenza vaccination complianceInfluenza vaccination recommendationsTetralogy of FallotQuality improvement initiativesAmbulatory pediatric cardiologyChest painInfluenza vaccinationKawasaki diseaseSecondary preventionVaccination recommendationsArterial switchCardiopulmonary bypassGreat arteriesSplenic functionVaccination compliancePreoperative method
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply